Literature DB >> 1801711

Probing the specificity of the bovine pituitary multicatalytic proteinase complex by inhibitors, activators, and by chemical modification.

S Wilk1, M Pereira, B Yu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1801711

Source DB:  PubMed          Journal:  Biomed Biochim Acta        ISSN： 0232-766X


× No keyword cloud information.
  5 in total

Review 1.  Structure and structure formation of the 20S proteasome.

Authors:  M Schmidt; G Schmidtke; P M Kloetzel
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

Review 2.  Proteasome inhibition: a new strategy in cancer treatment.

Authors:  J Adams; V J Palombella; P J Elliott
Journal:  Invest New Drugs       Date:  2000-05       Impact factor: 3.850

3.  Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.

Authors:  D Valmori; U Gileadi; C Servis; P R Dunbar; J C Cerottini; P Romero; V Cerundolo; F Lévy
Journal:  J Exp Med       Date:  1999-03-15       Impact factor: 14.307

4.  The proteasome inhibitor epoxomicin has potent Plasmodium falciparum gametocytocidal activity.

Authors:  Beata Czesny; Samrawit Goshu; James L Cook; Kim C Williamson
Journal:  Antimicrob Agents Chemother       Date:  2009-08-03       Impact factor: 5.191

5.  Discovery and development of the anticancer agent salinosporamide A (NPI-0052).

Authors:  William Fenical; Paul R Jensen; Michael A Palladino; Kin S Lam; G Kenneth Lloyd; Barbara C Potts
Journal:  Bioorg Med Chem       Date:  2008-11-05       Impact factor: 3.641
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.